Member Info for CJ39

I’ve sold out, that’s my trade at 08:27. Another loss made on this share.

I didn’t have a lot invested here. I lost £3300 when I sold out at 2.55p in the back end of last year. I bought approx 200,000 shares at about 0.85p in February. I know it’s not much but I don’t want to lose it, I’m here to make money, I would like to just experiment with this money now to see if I can make it grow with short term trading on shares which release good RNS’s each day.

I bought in after the dispute notice was issued, confident that there was an oversight or some small detail which EVG overlooked to meet the requirements of the milestone payment, after all EVG had stated they expected up to $5.5m this year in milestone payments and Stalicla stated on their website that this would go into phase 2 this year.

However clearly it’s not some small oversight, 15 weeks have passed without any update or news. As DSFlat pointed out, there are no updates on the data analysis by Stalicla and even Stalicla removed from their website that this would go into phase 2 this year. Doesn’t that say it all?

Everything has been so quiet on SFX-01, so little news in the last year. TCF cannot afford to do clinical trials on their main asset and no one is signing deals to trial it for their potential own gain. Everything seems to have dried up, with not a penny of income in the last 12 months.

The acquisition of the new company even feels like they ran out of work with SFX-01 and they have had to shelve their plans.

I sold my holding but it had to go to a negotiated order, again not a good sign when you can’t get prices to sell as they did give a price to buy.

Today is the last trading day before full results, uninspiring results could see this drop further, but positive encouraging results could see this rise. But can it really be positive given the year they’ve had?

It has been a rotten year, the share price is a disaster. We thought 2p was low, now we would need to see a rise of 300% just to get there. In one of the QnA’s last year they talked about wanting to get shareholder value, well they are not doing a very good job on it.

What a disappointment this share has proved to be.

Mcco, it has been nothing short of a disaster in the last 18 months here. After they announced the Stalicla deal in Oct 2022 which was worth $163m in milestone payments plus royalties, they had £10m in the bank, $6m to be received from Stalicla in 2023, Juvenesense deal was soon to go commercial, loads of things happening with SFX-01 trials, hopes of signing new deals, you can see why so many people bought in. But since then the following has happened: only $500k received from Stalicla, the $5.5m to be received in 2023 has still yet to be received, EVG/TCF issued a dispute notice 15 weeks ago to say that they believe they are owed $500k but we have heard absolutely nothing. Juvenesense deal ended before it went commercial, no real explanation given why Juve pulled the plug. The £10m has basically run out and a share placing was issued diluting the shares. No new deals signed for SFX-01. Hardly any news on SFX-01 trails. Are we close to SFX-01 going to go commercial? No, it’s a million miles off. Not sure of the current cash position but annual results are due out next week. I think we are all pleased for that as TCF never keep shareholders updated.

The only hope we have is that Stalicla have not pulled the plug, if they pay the $5.5m it will help but how long before any further money comes in? It’s not good here but its not over just yet, a stream of positive news could see this share price get back into the 2-3p range.

Thank goodness that the final results are due, I bet the board would say nothing to the shareholders about the Stalicla deal progress for another six months otherwise. Don’t expect too much positive news, TCF have not received a single penny of income in the last year apart from the share placing. I can’t believe how the news here has totally dried up. You never hear anything about SFX-01 nowadays.

Any further share placings will 100% mean it’s game over for shareholders here. I’m not sure how long the company is funded until, we will find out in the coming weeks when we get the year end results. They will surely be forced to give an update on the Stalicla deal in that.

You do have to wonder what all of the staff are doing for their salary. Is this why they acquired the new company as they had run out of work to do with SFX-01. All work on the drug is being done externally.

We need positive news about the Stalicla deal asap to turn this share around.

Yes in hindsight no one connected to EVG buying shares does seem significant now. To make out repeatedly that they would love to but can’t for legal reasons that they couldn’t go into is quite bizarre. It really does now appear that it was a made up excuse to avoid answering why they didn’t want to answer why they didn’t want to buy in.

Have you given up all hope here LWHL? I was confident after the dispute notice was issued that all would be resolved, afterall to put in a dispute notice made me feel confident that EVG had fulfilled their requirements and even on the Stalicla website at the time it said this would go into phase 2 in 2024. But almost 14 weeks have past and no news, whilst Stalicla removed from their website that this would go into phase 2 this year. Why would they remove that? I don’t know what is going on here but this Stalicla deal has cost us all dearly. I think most people here bought in because of this deal and after 19 months all EVG/TCF have received is $500k, not enough to fund the company more than 2 months.

DSFlat, that’s the first time I’ve seen you show any negativity about this share. For what it’s worth I think you were really unlucky with your original investment, I shared your thoughts entirely in late 2022. £10m in the bank, a $163m deal signed, guidance of $6m to be received by end of 2023, lots in the pipeline for SFX-01, Juvenesense deal coming along and to go active. I was sure this was a multi bagger when investing in late 2022. I really believed I would treble my money here.

How have we got from there to where we are today, share price going from 5p to 0.7p and troubled waters. Your subsequent top ups are questionable though, I know you wanted to average down your buy in price but pumping more money in just exposes you to potential larger losses. I just hope you haven’t put all your eggs in one basket.

I can’t agree with your comment that my post would be pointless as it is condescending if Stalicla weren’t messing TCF about. Alarm bells have been sounding here for a year now but people chose to ignore them. The delay now with Stalicla has been brewing for a year, it was clear something wasn’t right when EVG changed their guidance about when they would receive the $5.5m milestone payments a year ago without any explanation and that they have never factored in Stalicla money into any forecasts. Everyone includes expected income into their forecast.

As for my message being condescending, that wasn’t my intention. I have lost money here, we all have, it’s simply stating it’s a shame that on these message boards (not just EVG/TCF) when we all have the same goal to make money, that people dismiss anyone with negative criticism of a share as trolling rather than value an alternative opinion. For example I saw Kingalf talk up OBD on this and the OBD messageboard. I was intrigued. Then I saw xxxinvestorxxx write his sceptical views on the share which made me realise I don’t fancy it. Did I see xxxinvestorxxx as a troll? No. I valued his thoughts and it did actually save me money as I was tempted to invest a small amount.

Well done to those who held. It was my intention to hold after the dividend but the share price was falling and then the markets looked shaky when Israel and Iran attacked each other so I sold out at 460p. Disappointed I sold out now but you just never know what’s going to happen to the markets and share price. I can’t believe how high the FTSE100 is trading at, how much more can it go?

Do remember though to maximise your profits with Aviva you do need to sell at highs and buy in at lows. Holding without ever selling is just missed opportunities.

This share continues to be incredibly frustrating with the lack of updates and clarity of key issues.

It’s interesting just how quiet the posters are who were so positive of EVG/TCF and so critical of posters who were cautious and critical of the share for many different reasons.

I bought in at approx 5p after the Stalicla deal was announced and sold at 2.55p due to the confusion and change in information about when milestone payments would be received and the worry that a share placing would occur due to running out of funds. I was also unhappy at the lack of information about why Juvenesense pulled out and that the board instead of being disappointed said it was a good thing as they wanted to pursue bigger fish. Add to that the fibs about the board were not allowed to buy shares for legal reasons.

The amount of criticism Kingalf and I received on here, from being called trolls, talking nonsense, told to leave, etc was so disappointing. We see it a lot in life these days, look at JK Rowling how she has been bullied, attempted to be censored, cancelled, discredited for her views on gender ID. Same here, if you are critical of the share you get the same treatment. It’s bizarre, I don’t understand it. Even when I’m invested I value negative concerns far more than positive rampers. I don’t understand why such hostility towards people who post criticism and negativity of a share when it’s clearly deserved.

I hope you posters who were critical of us will change how you see posters who are sceptical, cautious and critical of a share in future and instead of being insulting will have an open mind and debate it. You may have saved a lot of money had you been more open minded.

I think that’s a really good possible theory investor. I agree that there is no sign that the deal is going to be pulled but there is some definite delay in payments and what you describe could be spot on. $5.5m is a lot of money to find.

It would also explain why TCF issued only a meagre share placing which only covered the cost of acquiring this new company.

I think it will go into phase 2 and this share price can increase 300% from here.

I've not given up hope that the partnership with Stalicla will go into phase 2 and either the milestone payments of $5.5m will be paid or Stalicla will aim to buy out TCF. Stalicla have not pulled the plug on the deal and on their website, in the pipeline section the arrow suggests that this is ready to go into phase 2. Until we get news on what is happening there is still hope but the fact it is May 2024 and still no further milestone payments or updates following on from the dispute notice is alarming and confusing. One RNS with a positive update on this will send this share price up past 2p, could be even 3p.

You have to wonder what are all the staff doing at TCF, it seems like any work done on SFX-01 is being done by external organisations. I think this is the reason EVG/TCF acquired this new company as they had run out of work. They couldn't afford to acquire this company without raising extra capital.

Don't give up hope yet.

I did wonder with the name change would we get some news of updates to get things going again but what was I thinking, of course not. Who thought on February 9th when we had the RNS advising that Evgen had issued a dispute notice that we would get to May 1st with no updates? They really do see shareholders as an inconvenience and that we don’t need to know what’s happening.

On a side note, I see on this site that they have already removed EVG’s whole page on here so can’t access old chat or RNS’s from here.

It’s alright in here isn’t it. See the last people in here left a decade ago. They left some cheese in the fridge but I found some tea bags in the cupboard.

Let’s hope this new name brings about a change in fortunes, it’s been a very poor last 18 months. But I have bought back in, 200k shares at 0.8p. It’s a bit of a gamble but good news with the Stalicla deal would see this rise past 2p easily. Still have no idea what’s going on with it but there has to be news soon.

Give us an update on the dispute notice issued to Stalicla.

This is promising. An investment company isn’t going to buy 20m shares if they are no wiser than us about the prospects in the company. Looks like they have invested £150k in EVG shares. I’m optimistic something is going to happen here soon.

Yes, if the Stalicla deal is ok then this is a great buy in price. When I originally bought in after the Stalicla deal was announced, 200,000 shares cost around £9k -£10k. You can now get 200,000 shares for £1600. Maybe I’ll lose most of this but if EVG announces they have received the $500k plus expect the other $5m before the end of the year this increases 300% from here. If Stalicla make an offer for EVG you’d like to think they’ll have to pay £20m+ which is around 5p a share and a 600% increase. Of course if EVG announce the Stalicla deal is over then this plummets yet further.

It’s now ten weeks since the dispute notice was issued. What on earth is going on here? You would think that this would be resolved in a phone call, have we fulfilled our commitments for the $500k milestone payment or not? If not what have we not done?

The good news is that Stalicla have not pulled the plug.

I’m starting to think that Stalicla are reluctant to pay any money as they want to buy out EVG, it would save them a fortune compared to the $160m milestone payments plus royalties. Could that be why EVG acquired a new company and raised cash in order to show Stalicla that they won’t be pushed about and EVG are in no hurry to sell cheaply? Is it why we’ve finally seen some of the board finally buy some shares? It feels like Stalicla paid the original $500k to test out SFX-01 and then make a decision to scrap the deal or buy out EVG.

The above could be totally wrong but it is possible. It’s risky buying in here but I’m going to buy back in, only a few hundred thousand shares. I’m not encouraging anyone else to do the same, but just thought I’d share my views.

It’s a fair write up xxxinvestorxxx. It is a fair balanced view you’ve given and I can understand you wanting to be positive and optimistic.

I do agree with LWHL that everything does rest on the Stalicla deal, if that was to fall through then this is worthless and the fact there is some problem is alarming. On a positive note it’s almost 10 weeks since the dispute was issued and Stalicla haven’t pulled the plug but god knows what is going on. I am of the impression that Stalicla have a deal in place costing $160m plus royalties but have realised EVG is worth peanuts and why not try and pick up EVG for next to nothing if the SFX-01 is effective and save an absolute fortune. Maybe that’s why they are not paying the $500k and delaying moving this into phase 2?

I was feeling really confident that this would pass the 5p mark before the dividend qualifying date. The results were excellent and the outlook even better. The share price was riding the crest of a wave, kept up momentum to 499p. But it fell a bit before the ex dividend date and again after it. Seems to be struggling to climb right now.

Where do you see this heading short/medium term? I’m apprehensive to be honest. It seems to be kicking off in the Middle East which will no doubt hurt the markets. The FTSE is very high right now, I can’t see it rising much further. There are no dividends for a while now, I’m thinking maybe to exit for the time being and jump back in when things seem a bit calmer. What are others doing?

We have qualified for the dividend now right?

It has all gone very quiet on here. Has everyone given up on it? This share had so much support, investors who 100% believed in the company.

I am really puzzled why there is still no update two months on. It obviously isn’t an oversight like many of us hoped. But it was clear there were problems last summer when EVG changed its guidance of $5.5m to be received by end of 2023 to ‘up to $5.5m expected in 2024. That raised alarm bells for me and I fortunately sold out at 2.55p.

What is clear is that the board know a lot more than they have told the mug shareholders. For example issuing shares last month to dilute the shares by 50%, why do that if they are expecting money imminently, especially after the new finance guy talked about wanting to create value for shareholders when he was appointed. But clearly even the board are puzzled as they issued a dispute notice believing they fulfilled their commitments. It seems like Stalicla are an awkward partner, it doesn’t bode well for future payments if they can’t even honour the second one.